The startup develops biodegradable implants utilizing patented delivery technology for nerve damage and regeneration. This approach provides targeted healthcare solutions for patients with injured nerves, facilitating effective recovery and minimizing long-term complications.
Funding
$230K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Peripheral nerve injuries resulting from trauma, cancer, or chronic diseases often lead to significant healthcare costs and long-term complications due to ineffective nerve regeneration. Current treatments may lack the ability to provide targeted drug delivery and optimal mechanical support for nerve repair.
Solution
Swan NeuroTech is developing a portfolio of biomaterial-based drug delivery technologies, including biodegradable nerve graft conduits and controlled drug-delivery systems, to address peripheral nerve injuries. The company's nerve graft conduits feature tunable polymer chemistry for improved mechanical properties, while its polymer microsphere technology allows for optimized drug-release kinetics. Swan NeuroTech utilizes additive manufacturing with a proprietary polymer dipping technology to create long-duration implants with safe degradation products. These implants aim to enhance nerve regeneration by providing structural support and targeted drug delivery to the injured site.
Target Audience
The primary target audience includes patients with peripheral nerve injuries resulting from trauma, cancer, or chronic diseases, as well as healthcare providers specializing in nerve repair and regeneration.
Features
- Nerve graft conduits with tunable polymer chemistry for improved mechanical properties
- Controlled drug delivery via polymer microsphere technology for optimized drug release kinetics
- Additive manufacturing using proprietary polymer dipping technology
- Biodegradable materials for long-duration implants with safe degradation products